Curcumin-based conjugates and methods of use thereof are provided. Pharmaceutical compositions including an effective amount of one or more curcumin conjugates are also provided. In particular embodiments, the compositions are formulated for oral delivery. The conjugates and pharmaceutical compositions thereof can be administered to a subject in need thereof to treat a host of diseases and disorders including but not limited to, cancer, inflammation, and microbial growth.

This document discloses molecules having the following formula (Formula One):

##STR00001##

and processes associated therewith.

This document discloses molecules having the following formula (Formula One):

##STR00001##

and processes associated therewith.

This document discloses molecules having the following formula (Formula One): ##STR00001##
and processes associated therewith.

This document discloses molecules having the following formula (Formula One): ##STR00001##
and processes associated therewith.

This document discloses molecules having the following formula (Formula One):

##STR00001##

and processes associated therewith.

Methods of and systems for remediating hydrazine spills, solutions, and hydrazine-contaminated objects including areas thereof comprise reacting 1,1-Dimethylhydrazine with -ketoacids and adding a reducing agent to the reaction of 1,1-Dimethylhydrazine with said -ketoacids.

Methods of and systems for remediating hydrazine spills, solutions, and hydrazine-contaminated objects including areas thereof comprise reacting 1,1-Dimethylhydrazine with -ketoacids and adding a reducing agent to the reaction of 1,1-Dimethylhydrazine with said -ketoacids.

This document discloses molecules having the following formula (Formula One): ##STR00001##
and processes associated therewith.

This document discloses molecules having the following formula (Formula One): ##STR00001##
and processes associated therewith.